王玮, 侯文文, 武丽俊, 许金环, 李文平, 闫旭, 张鹏举, 王钰琦, 赵绍宏. 手术切除肺腺癌患者术前CT征象与PD-L1表达的相关性研究[J]. 解放军医学院学报, 2023, 44(10): 1074-1080. DOI: 10.12435/j.issn.2095-5227.2023.037
引用本文: 王玮, 侯文文, 武丽俊, 许金环, 李文平, 闫旭, 张鹏举, 王钰琦, 赵绍宏. 手术切除肺腺癌患者术前CT征象与PD-L1表达的相关性研究[J]. 解放军医学院学报, 2023, 44(10): 1074-1080. DOI: 10.12435/j.issn.2095-5227.2023.037
WANG Wei, HOU Wenwen, WU Lijun, XU Jinhuan, LI Wenping, YAN Xu, ZHANG Pengju, WANG Yuqi, ZHAO Shaohong. Correlation between preoperative CT characteristics and PD-L1 expression in surgical resected lung adenocarcinoma[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2023, 44(10): 1074-1080. DOI: 10.12435/j.issn.2095-5227.2023.037
Citation: WANG Wei, HOU Wenwen, WU Lijun, XU Jinhuan, LI Wenping, YAN Xu, ZHANG Pengju, WANG Yuqi, ZHAO Shaohong. Correlation between preoperative CT characteristics and PD-L1 expression in surgical resected lung adenocarcinoma[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2023, 44(10): 1074-1080. DOI: 10.12435/j.issn.2095-5227.2023.037

手术切除肺腺癌患者术前CT征象与PD-L1表达的相关性研究

Correlation between preoperative CT characteristics and PD-L1 expression in surgical resected lung adenocarcinoma

  • 摘要:
    背景 复发和转移是影响肺腺癌患者外科手术治疗患者预后的重要因素,有临床研究显示将免疫检查点抑制剂应用于手术切除非小细胞肺癌的治疗可使患者获益,能否根据影像特征识别出适宜此疗法的人群是值得研究的问题。
    目的 探讨手术切除肺腺癌患者术前CT征象与术后PD-L1表达水平的相关性,为免疫治疗的筛选提供影像依据。
    方法 收集2021年1 - 3月于解放军总医院第一医学中心胸外科行手术切除的肺腺癌患者资料。纳入具有术前胸部薄层CT图像、术前未做穿刺或治疗、术后检测有PD-L1表达的浸润性肺腺癌病例。取检测结果肿瘤细胞PD-L1阳性比例分数(tumor proportion score,TPS)=1%为截断值,分为阴性组(TPS<1%)和阳性组(TPS≥1%),分析两组临床资料和CT征象差异。使用Logistic回归分析PD-L1表达的关联因素,并使用ROC曲线评估其诊断效能。
    结果 共纳入306例患者的308个病灶,其中136个肿瘤组织病理示PD-L1表达阳性,172个表达阴性。单因素分析显示,男性、吸烟史、肺癌家族史、病灶密度、CTR值、平均CT值、最大直径、毛刺征和胸膜凹陷征与PD-L1表达相关(P<0.05)。多因素分析结果示,肺癌家族史(OR=2.876,95% CI:1.257 ~ 6.578)和病灶CTR值(OR=4.321,95% CI:1.165 ~ 16.036)与PD-L1表达关联。纳入肺癌家族史和CTR值的回归模型Ln(P/1-P)=1.464 × CTR + 1.056 × 肺癌家族史预测PD-L1表达的AUC为0.682,敏感度为64.7%,特异度为69.2%。
    结论 对可手术切除的肺腺癌患者,一般临床资料和影像征象可为判断PD-L1表达水平提供一定信息,肺癌家族史和病灶CTR值是PD-L1表达的关联因素。

     

    Abstract:
    Background  Recurrence and metastasis in patients with surgical treatment of lung adenocarcinoma are important factors affecting prognosis. Clinical trials have shown that immunocheckpoint inhibitors can benefit patients in the treatment of complete resected non-small cell lung cancer, and the use of imaging features to identifying the appropriate population for this treatment is worthy of investigation.
    Objective To explore the correlation between preoperative CT imaging characteristics and PD-L1 expression detected postoperatively in complete resected lung adenocarcinoma, so as to provide imaging evidences for immunotherapy selection.
    Methods From January to March in 2021, patients with invasive lung adenocarcinoma who underwent surgical resection in the Department of Thoracic Surgery of the First Medical Center of Chinese PLA General Hospital were included, and PD-L1 expression was divided into negative group (TPS<1%) and positive group (TPS≥1%) with a cut-off value of tumor proportion score (TPS)=1%. The clinical and imaging data of two groups were analyzed. Binary logistic regression analysis was used to detect factors that had a correlation effect on PD-L1 expression and ROC curve was used to evaluate its efficacy.
    Results A total of 308 lesions from 306 patients were enrolled, of which 136 lesions were in positive group and 172 in negative group. Univariate analysis showed that male, smoking history, family history of lung cancer, lesion density, CTR, mean CT value, the maximum diameter, spiculation and pleural indentation were correlated with PD-L1 expression. Multivariate analysis showed that family history of lung cancer (OR=2.876, 95%CI: 1.257-6.578) and CTR value (OR=4.321, 95%CI:1.165-16.036) were closely correlated with PD-L1 expression, and AUC of the regression model was 0.682, with a sensitivity of 64.7% and a specificity of 69.2%.
    Conclusion The family history of lung cancer and CTR are significantly correlated factors for PD-L1 expression of completely resected lung adenocarcinoma.

     

/

返回文章
返回